8th European Multidisciplinary Meeting on Urological Cancers
Presenting the current state of the art in onco-urology, with particular emphasis on the diagnosis and treatment of cancer.
In conjuction with:
- European School of Urology (ESU)
- 5th Meeting of the EAU Section of Urological Imaging (ESUI)
- 2016 EMUC Symposium on Genitourinary Pathology and Molecular Diagnostics (ESUP)
- EAU Young Academic Urologists Meeting (YAU)
European Meeting on Urological Cancers (EMUC), an international multidisciplinary conference for uro-oncology experts where insights, best practices and prospects are discussed and examined in a comprehensive and critical manner by opinion leaders.
Focusing on controversial diagnostic issues and treatment strategies, EMUC organisers harness the synergies of the European Society for Medical Oncology (ESMO), the European SocieTy for Radiotherapy & Oncology (ESTRO) and the European Association of Urology (EAU) to offer a scientific programme that directly addresses core topics and emerging trends in urological malignancies.
With the collaboration of partners and affiliated organisations such as the European School of Urology (ESU), the EAU Section of Urological Imaging (ESUI), EAU Young Academic Urologists Meeting (YAU) and the EAU Section of Uropathology (ESUP), the EMUC has established in the last eight years a reliable and dynamic platform for medical oncologists, radiologists, pathologists and urologists to share knowledge and expertise.
Identifying best practices and assessing forward-thinking approaches, the EMUC is anchored on efficient multidisciplinary collaboration and its pivotal role in delivering optimal healthcare. Now approaching its first decade, the EMUC stays close to its aim of continually improving the clinical and research work of specialists in onco-urology.
We look forward to see you in Milan in 2016 for yet another collaborative and dynamic exchange!
Trends in genitourinary pathology and impact on clinical practice
New trends and developments in genitourinary pathology and their impact on current clinical practice were examined and discussed by specialists and experts during a special EMUC16 event.
> Read more
Imaging-guided approaches for PCa recurrences
Current treatment strategies that employ image-guided approaches for prostate cancer recurrences were examined with experts exploring options in radiotherapy, surgery and chemotherapy.
> Read more
Kidney cancer: From diagnosis to progression
Improving diagnosis and mapping out optimal treatment strategies for kidney cancer patients topped the second-day agenda of EMUC16.
> Read more